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Fetal Abdominal Wall Repair with a Collagen Biomatrix 
in an Experimental Sheep Model for Gastroschisis
Luc A. J. Roelofs, M.D.,1 Alex J. Eggink, M.D.,2 Christina A. Hulsbergen-van de Kaa, M.D., Ph.D.,3 
Paul P. van den Berg, M.D., Ph.D.,4 Toin H. van Kuppevelt, Ph.D.,5 
Herman T. B. van Moerkerk,5 A. Jane Crevels,4 Fred K. Lotgering, M.D., Ph.D.,2 
Wout F. J. Feitz, M.D., Ph.D.,1 and Rene M. H. Wijnen, M.D., Ph.D.6
We evaluated the regeneration of the abdom inal wall using a dual-layer collagen biomatrix, and the protective 
effect on the bowel of fetal abdom inal wall repair in a fetal sheep m odel for gastroschisis. In 14 fetal lambs, the 
abdom inal wall was opened at 79 days' gestation, creating a gastroschisis. In group 1, the gastroschisis was left 
uncovered. In group 2, the bowel was repositioned, and the defect was closed by suturing a collagen biomatrix 
into the abdom inal wall. A cesarean section w as perform ed at 140 days' gestation, and macroscopic and his­
tological evaluation was performed. In the five lambs w ith a gastroschisis, the eviscerated part of the bowel was 
coalescent, showed extensive adhesions, and was covered by  fibrous peel. In group 2, the abdom inal wall had 
closed, w ith a firm connection to the native abdom inal wall. The biomatrix w as largely degraded and replaced 
by  connective tissue w ith  collagen and fibroblasts, neovascularisation, and scattered muscle cells. M inor or no 
adhesions of the bowel and no peel formation were observed. Abdom inal wall tissue replacement using a 
collagen biomatrix was feasible in fetal lambs, resulting in a closed abdom inal wall at birth. Im m ediate closure of 
the gastroschisis strongly dim inished or prevented bowel adhesions and peel formation.
Introduction
Su r g i c a l  c l o s u r e  of congenital abdominal wall defects can be a complex problem for pediatric surgeons. An 
important group is patients with gastroschisis. Gastroschisis 
is an abdominal wall defect through which a large part of the 
bowel is herniated outside the abdominal cavity and is in 
direct contact with the amniotic fluid. The mortality in these 
children is approximately 10%, but intra-uterine growth re­
tardation and premature birth are frequent, and serious 
complications such as sepsis, bowel dysfunction, bowel 
atresia, bowel necrosis, and subsequent short bowel syn­
drome can occur.1-4 At birth, the bowel is often covered with 
an inflammatory fibrous peel; the bowel loops are matted 
together and can be congested or ischemic; and the bowel is 
thickened, inflamed, and edematous. Constriction of the 
bowel at the site of the abdominal wall defect and the toxic 
effect of the amniotic fluid cause this damage to the bowel.5,6 
The damage to the bowel seems to originate during the last 
trimester of pregnancy. At that time, the bowel is growing, 
and compression at the abdominal wall defect will occur.
Furthermore, the composition of the amniotic fluid is 
changing because of improving kidney function and the loss 
of gastrointestinal waste products.7-11 The surgical repair of 
these defects can be complicated using difficult primary 
closure because of the hypoplastic abdominal cavity and the 
enlarged volume of the bowel because of edema and peel 
formation. An increase in intra-abdominal pressure can oc­
cur after repositioning the bowel in the abdominal cavity, 
causing respiratory problems and compromised venous 
blood flow. In these cases, a gradual closure with a spring- 
loaded silo is chosen.12 In some cases, even prosthetic ma­
terials are needed to close the abdominal wall defects or the 
fascia defects. These materials may also cause complications, 
such as wound infection, bowel fistula, erosion into ab­
dominal viscera, lack of fixation, mesh extrusion, and adhe­
sion formation.13 Furthermore, patch dehiscence may occur 
because the material does not grow with the child.14 Gas- 
troschisis can be detected in early pregnancy,15 which of­
fers the opportunity to salvage the bowel tissue using fetal 
therapy. Tissue-engineered constructs could be a solution for 
the operative closure of these defects.
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The purpose of this study was to repair the full-thickness 
defect in the abdominal wall in fetal lambs with a surgically 
created gastroschisis using a molecularly defined acellular 
collagen biomatrix to induce regeneration of abdominal wall 
tissue, and to protect the bowel. We evaluated tissue regen­
eration in the biomatrix, the inflammatory response, the pro­
tective effect of abdominal wall closure with the biomatrix 
on bowel tissue, adhesions of the biomatrix to underlying 
tissue, and the presence of hernias.
Materials and Methods
The Ethical Committee on Animal Research of the Rad­
boud University Nijmegen Medical Centre approved this 
study under protocol number RUDEC 2003-96.
Preparation of collagen biomatrices
The molecularly defined, biocompatible, biodegradable 
dual-layer collagen biomatrices were made from insoluble 
highly purified type I collagen from bovine Achilles tendon.16 
The biomatrix consisted of a porous layer and a dense film 
layer. A 0.8% (w/v) type I collagen suspension was shaken 
overnight in 0.25 M acetic acid at 4°C and homogenized on ice 
using a Potter-Elvehjem homogeniser. Air bubbles were re­
moved by centrifuging at 250 g for 10 min at 4°C. The sus­
pension was slowly poured into a plastic mold (4 mL per 0  
32 mm), and air-dried for 3 days at 22°C to prepare a flat film 
layer. These films were incubated for 60 min in 4mL 0.25 M 
acetic acid. Acetic acid was then removed, and a suspension of
4 mL 0.8% type I collagen in 0.25 M acetic acid was poured on 
top of the films, quickly frozen at —80°C, and lyophilized in a 
Zirbus lyophiliser (Bad Grund, Germany). Scaffolds were 
cross-linked using 33 mM 1-ethyl-3-(3-dimethyl aminopro- 
pyl)carbodiimide and 6 mM N-hydroxysuccinimide in 50 mM 
2-morpholinoethane sulphonic acid pH 5.0 containing 40% 
ethanol (5 mL per 0  32 mm) for 4 h at 22°C. Scaffolds were 
then washed with 0.1 M disodium hydrogen orthophosphate, 
1 M sodium chloride (NaCl), 2 M NaCl, and MilliQ water, 
frozen again in ethanol/carbon dioxide, and lyophilized.17,18 
Biomatrix morphology was assessed using scanning electron 
microscopy (Fig. 1).17,18 The porous layer had interconnective 
pores, and the mean average pore size of the top side of the 
porous layer was 106 ±  22 mm and of the cross-section was 
123 ±  34 mm (average of 100 pores of three individually pre­
pared biomatrices). The porous layer and film layer had an 
average diameter of 1.5 mm and 2 to 3 mm respectively. Cross­
linking was verified according to its amine group content, and 
48% of the amine groups were used in the crosslinking pro- 
cess.17 Before implantation, the matrices were washed in 70% 
(v/v) ethanol and sterile phosphate buffered saline.
Surgical procedures
Fourteen pregnant sheep (Dutch Texels breed) were op­
erated on at 79 days' gestation (full term 140-147 days). An 
intravenous injection of 30 m g/kg pentobarbital and 1 mL 
atropine was used for anesthesia and, following endotra­
cheal intubation, was maintained with 2% isoflurane and 
oxygen/air ventilation at a respiration rate of 16 breaths per 
minute. The uterus was exteriorized through a midline ab­
dominal incision. A hysterotomy was performed, and the 
lower part of the fetal body was exposed. In case of twin or
FIG. 1. Dual-layer collagen biomatrix (scanning electron 
microscopy). (A) Film layer of biomatrix; (B) porous layer of 
biomatrix.
triplet pregnancy, only one fetus was operated on to avoid 
additional risk of complications.
The animals were divided into two groups. In group 1, 
consisting of five fetuses (two male, three female), a 
gastroschisis was surgically created. An incision of 2.5 cm 
was made in the left lower quadrant of the abdominal wall of 
the fetuses, through skin and fascia, resulting in a full­
thickness abdominal-wall defect of approximately 2.5x2 cm. 
The defect was left-sided to avoid injury to the liver by 
surgical manipulation. Subsequently, the bowel was exposed 
and gently extruded from the abdominal cavity (Fig. 2A). 
The lesion was left uncovered, leaving the bowel exposed to 
the amniotic fluid.
In group 2, consisting of nine fetuses (seven male, two fe­
male), a gastroschisis was created as in group 1. Subsequently, 
the bowel was gently manipulated back into the abdominal 
cavity, and the dual-layer collagen biomatrix, measuring ap­
proximately 2.5x2 cm was placed into this defect (film layer at 
the luminal site). The biomatrix was sutured in the abdominal 
wall using 6-0 poliglecaprone (Monocryl, Ethicon, Inc., Som- 
merville, NJ) interrupted sutures (Fig. 2B). Four 6-0 polypro­
pylene (Prolene, Ethicon, Inc.) marking sutures were placed 
around the biomatrix for future reference.
After the surgical procedure, the fetus was returned to 
the uterus and amniotic fluid volume was restored using 
warm sterile saline together with amoxycilline 250 mg. The 
uterus was closed in two layers using a 2-0 polyglactin 
(Vicryl, Ethicon, Inc.) running suture. Sodium-penicillin 
(1,000,000 IU) was instilled into the intra-abdominal space, 
and the maternal laparotomy was closed in two layers using 
1 polyglactin interrupted sutures. Depomycine (20 mg/kg, 
subcutaneous) was initiated preoperatively and maintained 
postoperatively for 3 days.
At 140 days' gestation, 61 days after surgery, the lambs 
were delivered by caesarean section under local anaesthesia
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FIG. 2. Fetal lambs operated on at 79 days' gestation. (A) Surgically created gastroschisis. (B) Surgically created abdominal 
wall defect closed with collagen biomatrix.
with 20 to 30 mL Lidocaine 2%, administered subcutaneously 
and intramuscularly.
Neonatal outcome and evaluation
After birth, the macroscopic appearance of the bowel was 
observed and photographed in group 1, and the size of the 
defect was measured. The replaced part of the abdominal wall 
at the place of the incorporated biomatrix in group 2 was 
macroscopically observed, palpated, photographed, and 
measured. Subsequently, the lambs were sacrificed using 
medetomidine (0.5 mg intramuscular) and pentobarbital 
(60 m g/kg intracardial). Afterward, the abdominal wall of the 
lambs from group 1 was opened, and the bowel was taken out 
from pylorus to rectum, with a small part of the adhering
abdominal wall. The intra- and extra-abdominal part of the 
bowel was evaluated for adhesions and fibrous peel.
The abdominal wall of the lambs from group 2 was opened 
with broad margins around the site of the former biomatrix. 
Intra-abdominal adhesions were observed and photographed. 
The abdominal wall and the bowel, from pylorus to rectum, 
were taken out.
Histological staining
From the lambs of group 1, tissue samples were taken 
from the bowel situated outside of the abdominal cavity and 
from bowel inside the abdominal cavity. In group 2, samples 
from the replacing tissue at the site of the implanted col­
lagen biomatrix and tissue samples of the bowel lying
FIG. 3. (A) Macroscopic aspect of the surgically created gastroschisis (group 1), after birth, showing coalescent bowel loops 
covered with fibrous peel. (B) Histological picture of the bowel wall of a lamb from group 1, after birth, showing the fibrous 
peel. Arrows =  pseudoepithelial layer of mesenchymal cells; F, fibrous peel; S, subserosal layer; M, intestinal muscularis; Su, 
submucosa; Mu, mucosa (hematolyxlin and eosin (H&E) staining, original magnification x50). (Magnification of rectangle in 
inset). Inset: PE, pseudoepithelial layer of mesenchymal cell; CF, collagen and fibroblasts (H&E staining; x40).
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underneath the site of the implanted collagen biomatrix were 
taken. Tissue samples of normal bowel of five lambs that had 
undergone a fetal operation in another study served as 
controls.
The tissue samples were fixated in 4% buffered formalin 
and paraffin embedded for routine histological processing. 
Sections (4 mm) were cut and stained with hematoxylin and 
eosin and Masson's trichrome. The intestinal tissue of the 
lambs was examined for changes in the mucosal, submucosal, 
muscle, and serosal layers and peel and adhesion formation. 
Two bowel samples were used from each fetus to assess the 
thickness of the intestinal muscularis and the serosal peel 
layer in three random fields with an ocular micrometer at 
magnification x100. The specimens, which included the site of 
the implanted collagen biomatrix in the abdominal wall, were 
examined for evidence of epithelialization, smooth muscle cell 
growth, neovascularization, and degradation of the biomatrix. 
In addition, the thickness of the replacing tissue was mea­
sured using the ocular micrometer. Immunohistochemical 
staining was performed using desmin for staining of muscle 
cells and S-100 staining to visualize nerve fibres.
Data analysis
Data analysis of the bowel measurements was performed 
using SPSS 12.0 for Windows (SPSS, Inc., Chicago, IL) and 
expressed as means ±  standard deviations. Statistical analy­
sis was performed using one-way analysis of variance. 
P < 0.05 was considered statistically significant.
Results
Eleven of the 14 operated fetuses (79%) were born alive. 
Two fetal deaths occurred in group 2 without a clear reason; 
the lambs were found macerated at the caesarean section. 
One ewe was euthanized because of an infection in the fascia 
of the abdominal wall, resulting in uncorrectable fascia de­
hiscence. No further maternal deaths occurred.
The five control lambs showed no macroscopic or histo­
logical bowel changes. At histological examination, the se­
rosa measured 0.02 ±  0.01mm and the intestinal muscularis
0.08 ±  0.03 mm.
After birth, four lambs of group 1 showed eviscerated 
bowel covered with a fibrous peel; in two lambs, a thick layer 
was present, and in two lambs a clearly thinner layer of 
fibrous peel was visible (Fig. 3A). In one lamb, the bowel had 
spontaneously repositioned into the abdominal cavity, and 
the abdominal wall had closed with a small scar. The bowel 
of this lamb was enveloped in a sac, with the same appear­
ance as the fibrous peel. The eviscerated bowel package of 
the other four lambs measured approximately 7x5x5 cm in 
size, and the size of the abdominal wall defect was 5 cm. The 
eviscerated part of the bowel was coalescent and showed 
extensive, inseparable adhesions. The intra-abdominal part 
of the bowel also showed adhesions, although of a much 
lesser extent than the eviscerated bowel. No atresia or other 
bowel abnormalities were seen.
Histological examination of the intestines of the gastro- 
schisis lambs (group 1) showed that the serosa of the four 
lambs with the eviscerated bowel was covered with fibrous 
peel. In two lambs, the fibrous peel was thick (mean diam­
eter 1.37 ±  0.36 mm and 2.64 ±  0.91mm). The peel consisted 
of deposited fibrin and degenerated granulocytes, granula­
tion tissue with chronic inflammation (focal foreign body 
giant cells around hair remnants, plasma cells, lymphocytes, 
and histiocytes), fibrosis, and focal hemosiderin pigment. In 
two lambs, the fibrous peel was thinner (0.75 ±  0.23 mm) and 
without inflammation. In these lambs, a pseudo-epithelial 
mesenchymal layer of cells, which seemed to protect the 
bowel tissue against the amniotic fluid, covered the peel (Fig. 
3B). No edema, venous dilatation, lymphatic dilatation, or 
signs of ischemia were seen in the bowel tissue. The mucosa 
appeared normal, with normal villi, and the submucosa was 
normal, without collagen deposits. The intestinal muscularis 
showed some thickening (0.14 ±  0.05 mm) with collagen de­
position; normal ganglion cells were seen. The bowel of the 
lamb with the spontaneously closed defect showed no ab­
normalities, with a normal serosal layer (mean diameter
0.02 mm).
The six surviving lambs of group 2 showed a closed ab­
dominal wall; the replacing tissue was visible between the 
marking sutures in the skin after shaving, measuring ap­
proximately 3.2 ±  0.8 cm in diameter (Fig. 4A). The replacing 
tissue was of strong consistency; in one lamb, a small her­
niation in the abdominal wall of 1.5 cm was palpable under 
the skin, and in the other lambs, no herniations were pal­
pable. In the center, a hyperkeratotic area was seen in five of 
six lambs, and the surrounding tissue formed a ridged con­
figuration. Underneath this regenerated tissue, the bowel 
had a normal appearance, no adhesions between bowel 
loops were visible, and only some minor adhesions between 
the bowel and the abdominal wall existed (Fig. 4B). The 
bowel tissue in these lambs appeared normal on histologi­
cal examination. No peel formation was found; the serosal 
layer (0.02 ±  0.01mm) and the intestinal muscularis (0.08 ±
0.03 mm) were of normal thickness and significantly thinner 
(both p < 0.001) than in gastroschisis lambs. The submucosa 
and mucosa appeared normal (Fig. 4C). Histological exami­
nation of the abdominal wall showed tissue replacement 
throughout the entire biomatrix in all lambs. Connective 
tissue, with collagen and fibroblasts, was largely replacing 
the biomatrix. There was a firm connection with the adja­
cent skin, subcutaneous tissue, and muscle of the native 
abdominal wall. The replacing tissue was thinner than the 
native abdominal wall, with the native abdominal wall 
measuring 6.2 ±  1.4 cm and the replacing tissue 3.6 ±  1.4 cm 
(Fig. 5A, B, D). On the outside, the entire replacing tissue 
was covered with skin tissue in all lambs. The skin tissue 
was more mature at the edges of the newly formed tissue, 
with epithelialization and adnexal differenattiation, in­
cluding sebaceous glands and hair follicles, than at the 
center of the tissue (Fig. 5A). Tissue replacement occurred 
from the borders of the regenerated tissue. Hyperker- 
atinization was visible at the center of this tissue in five of 
six lambs (Fig. 5B). Good neovascularization was seen 
throughout the entire replacing tissue, at the borders as well 
as the center of this tissue (Fig. 5A-C). The angiogenesis 
seemed to originate from the peritoneum and the edges of 
the native abdominal wall. Only minor inflammatory reac­
tion was seen, without a foreign body reaction. The collagen 
biomatrix was largely degraded, except for the less-porous 
film layer, which was still visible at the inside of the ab­
dominal wall (Fig. 5A-C). A small number of scattered 
muscle cells were visible in the replacement tissue, sur­
rounded by myofibroblasts, but no muscle bundles were
FIG. 4. (A) Abdominal wall defect closed using a collagen biomatrix (group 2), macroscopic aspect after birth, showing 
a closed abdominal wall with regenerated skin tissue. (B) Minor adhesions visible (arrows) in a lamb from group 2. 
(C) Histological picture of the bowel of a lamb from group 2, showing no abnormalities. Se, serosal layer; M, intestinal 
muscularis; Mu, mucosa (hematolyxlin and eosin staining; original magnification x50).
FIG. 5. Histological imges of the replacing tissue at the side of the abdominal wall defect closed using a collagen biomatrix 
(group 2). (A) Overview of replacement tissue showing that regenerated skin and connective tissue replaced the biomatrix. 
The regenerated skin tissue (RS) (=  between RS) at the border was more mature, with hair follicles and sebaceous glands, 
than at the center (CR). The replacement tissue was thinner than the native abdominal wall. Remnants of the film layer (RF) 
and porous layer (RP) were visible. NS, native skin; Bo, bowel. (Hematolyxlin and eosin (H&E) staining; original magnifi­
cation x12.5). Inset on the left: magnification of the ellipse at the overview, showing epidermis (EP), collagen and fibroblasts 
(CF), and hair follicle and sebaceous gland (HS) (H&E staining; x40). Inset on the right: nerve fiber in regenerated tissue 
(arrows) (S-100 staining; x200), located at the rectangle in overview. (B) Overview of regenerated tissue, showing the border 
between native skin (NS) and native muscle (NM) and the replacement tissue (R). The skin is covered with a hyperplastic 
epidermis with hyperkeratinization (E). AB, abdominal site. (H&E staining; original magnification x25). (C) Connective tissue 
formation, with fibroblasts and collagen (F) and mature vessels (V). RP, remnant of porous layer biomatrix. (Magnification of 
rectangle in Fig. 5B). (H&E staining; x100). (D) Replacement tissue (R) with scarce smooth muscle cell formation (M). The 
native muscle (NM) was partially degenerated (DM). AB, abdominal site. (Desmin staining; x12.5). (E) Magnification of 
smooth muscle cells; yellow arrows =  rounded striated muscle cells; black arrows =  spindle-shaped myofibroblasts. (Mag­
nification of rectangle in fig. 5D). (Desmin staining; x200).
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seen (Fig. 5D, E). Only few nerve fibers could be found in 
this tissue (Fig. 5A).
Discussion
Fetal therapy has been applied for several congenital 
anomalies in experimental settings. This was first performed 
in life-threatening anomalies, but nowadays it is also used for 
the treatment of non-fatal anomalies, as in gastroschisis.2 The 
survival rate in gastroschisis patients is commonly greater 
than 90%, but various problems may arise after birth, and 
some report a postnatal complication rate of 79%.4 The 
damage to the bowel is assumed to occur during late preg­
nancy, due to constriction of the bowel at the abdominal wall 
defect and exposure to the amniotic fluid.5 Early detection of 
gastroschisis during pregnancy is possible using routine ul­
trasound screening and offers the opportunity for early 
treatment during the fetal period, to protect the bowel tissue 
against further secondary injury. Till et a l  successfully re­
paired the abdominal wall of rabbit fetuses with a surgically 
created gastroschisis using operative closure, but the follow- 
up period was negligible.19 Tissue-engineering techniques 
have been used to close abdominal wall defects in adult an­
imals. In these studies, full- or partial-thickness abdominal 
wall defects were surgically created, and scaffolds of extra­
cellular matrix were used to close these defects, resulting in 
firm connective tissue formation, degradation of the scaffold, 
and some reported regeneration of skeletal muscle.14,20-25 
Acellular scaffolds have also been used experimentally in 
small numbers of humans with large abdominal wall defects 
that were inappropriate for primary closure.26,27 In previous 
work, we used a collagen biomatrix to cover a surgically 
created neural tube defect in fetal lambs.28,29
In the present study, we used the fetal lamb model for 
surgical creation of gastroschisis. The lambs in which the 
bowel was left eviscerated out of the abdomen showed 
macroscopic and histological similarity with gastroschisis in 
humans. Extensive adhesions and peel formation were seen 
in these lambs.
In one lamb, the bowel had repositioned in the abdomen, 
and the abdominal wall had closed. Spontaneous intra­
uterine closure of the defect in humans has been reported, 
accompanied by intestinal involution resulting in intestinal 
atresia.15,30 In our animal model, the defect in the abdominal 
wall was larger than the defects in humans, which may ex­
plain the spontaneous repositioning of the bowel in one 
lamb, and the absence of signs of bowel constriction at time of 
birth.
In the other group, the full-thickness abdominal wall defect 
was immediately repaired using a collagen biomatrix, and the 
regeneration of abdominal wall tissue and possible changes 
of the bowel were studied. We used a molecularly defined, 
biocompatible, biodegradable dual-layer biomatrix of highly 
purified type I collagen, which is a modification of the bio­
matrix previously used for fetal closure of spina bifida, to 
repair the abdominal wall. 28,29,31 The modification consisted 
of adding an additional thin layer of collagen with less po­
rosity and higher strength capabilities, to increase the total 
tensile strength of the biomatrix. In all lambs, the defect in the 
abdominal wall had closed after birth. Histological exami­
nation showed that the porous layer of the biomatrix was 
largely degraded, but the film layer resided. Connective
tissue and skin formation replaced the porous layer of 
the collagen biomatrix. Good neovascularization occurred 
throughout the entire replacement tissue. No inflammatory 
response to the biomatrix was visible. It is likely that this was 
due to the use of highly purified collagen, instead of decel- 
lularized tissue that is often used in other animal studies. The 
tissue appeared to be firm and was well incorporated into the 
native abdominal wall tissue. In one lamb, a small herniation 
was palpable; in the other five lambs, no herniations oc­
curred. Only a small group of muscle cells was seen in the 
repaired area, surrounded by spindle-shaped myofibroblasts. 
Some groups have reported varying degrees of muscle re­
generation,21-25 but the follow-up period of 61 days in our 
study could be too short; the tissue would probably have 
developed further during the postnatal period if the lambs 
had not been sacrificed. The bowel appeared normal on 
macroscopic and histological examination. Only minor ad­
hesions between the bowel and the abdominal wall occurred 
with this collagen scaffold, without further complications, 
and no peel formation or inflammatory reaction was seen in 
the bowel. Immediate closure of the abdominal wall defect 
prevented these alterations.
In human studies in which a collagen biomatrix was used 
to close abdominal wall defects, the major disadvantage was 
the low tensile strength of the collagen biomatrix, especially 
when degradation of the collagen occurred.13 By modifying 
the biomatrix using chemical cross-linking of the collagen, the 
degradability can be adjusted to make it more appropriate for 
abdominal wall closure, and the strength is greater.16-18 The 
addition of the film layer with less porosity further improves 
the strength and maintains this strength for a longer period 
because of its lower degradability. Furthermore, improved 
regeneration of the muscle and fascia would also provide 
extra strength to the newly formed tissue. A possible strategy 
of improving the regeneration could be the incorporation of 
growth factors into the biomatrix to enhance neovasculariza­
tion and ingrowth of (muscle) cells. The incorporation of au­
tologous muscle cells also seems to improve cell infiltration 
and mechanical performance.22-25,32,33 However, this tech­
nique may be inappropriate for fetal operations, because an 
additional operation for muscle biopsies will then be needed, 
increasing the risk of complications.
The use of biomaterials can be a promising tool for pa­
tients with an abdominal wall defect to regenerate the ab­
dominal wall or cover the eviscerated bowel. Fetal therapy 
may have its advantages in these patients; early coverage 
of the bowel could prevent inflammatory changes and ad­
hesion formation and might salvage the bowel function. 
Furthermore, the defect is smaller at this point, adequate 
neovascularization may be obtained throughout the entire 
biomatrix, and the incongruence of volumes between the 
abdominal cavity and the bowel is smaller than in neona­
tes. Fetal wound healing has a strong potency and can 
even result in scarless wound healing.34 By repairing these 
defects at the fetal stage, the advances of the regenera­
tive capacity of the fetus are used. However, in our model, 
the regeneration process took place during gestational 
weeks 11 through 20, which is largely during the third tri­
mester. Scarless wound healing and the regenerative capac­
ity of the fetus decrease when the fetus is nearing full term, 
and near term it will be comparable with postnatal wound 
healing.34
FETAL ABDOMINAL WALL REPAIR WITH A COLLAGEN BIOMATRIX 2039
Currently, the major disadvantage of fetal surgery is the 
risk of complications leading to premature delivery.35,36 
However, with improvements in the techniques for fetal 
access, it can become a promising tool for patients with this 
congenital anomaly in the near future.
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